SCHEMBL1233922

SCHEMBL1233922

OC1=C[CH]CC=C1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11548175 0.75
SCHEMBL2152773 0.75
SCHEMBL9066885 0.55
SCHEMBL1884889 0.55
SCHEMBL14949882 0.51
SCHEMBL6718535 0.50
SCHEMBL329462 0.50
Phloroglucinol SCHEMBL483877 0.45 BACE1 (0.73)
SCHEMBL20891 0.45
SCHEMBL3151557 0.45

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3193815-A1 METHODS AND MATERIALS FOR DELIVERING AGENTS TO HAIR, SKIN, OR NAILS SafeWhite, Inc. (US) 2017-07-26 EP claimed
US-9688777-B2 Protein-polymer complex, TGase substrate-containing polymer, TGase substrate-containing monomer, method for producing protein-polymer complex, and method for improving protein function at solid-liquid interface or in vicinity of solid-liquid interface HITACHI, LTD. (JP) 2017-06-27 US claimed
EP-3066207-A1 BENZYLISOQUINOLINE ALKALOID (BIA) PRECURSOR PRODUCING MICROBES, AND METHODS OF MAKING AND USING THE SAME The Board Of Trustees Of The University Of the Leland Stanford Junior University (US) 2016-09-14 EP claimed
US-20160251450-A1 PROTEIN-POLYMER COMPLEX, TGase SUBSTRATE-CONTAINING POLYMER, TGase SUBSTRATE-CONTAINING MONOMER, METHOD FOR PRODUCING PROTEIN-POLYMER COMPLEX, AND METHOD FOR IMPROVING PROTEIN FUNCTION AT SOLID-LIQUID INTERFACE OR IN VICINITY OF SOLID-LIQUID INTERFACE KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2016-09-01 US claimed
US-9388454-B2 Method for producing protein-nucleic acid conjugate, and method for detecting target substance KYUSHU UNIVERSITY, NAT'L UNIVERSITY CORPORATION (JP) 2016-07-12 US claimed
WO-2016044582-A1 METHODS AND MATERIALS FOR DELIVERING AGENTS TO HAIR, SKIN, OR NAILS SAFEWHITE, INC. (US) 2016-03-24 WO claimed
US-20150284762-A1 METHOD FOR PRODUCING PROTEIN-NUCLEIC ACID CONJUGATE, AND METHOD FOR DETECTING TARGET SUBSTANCE KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2015-10-08 US claimed
WO-2015066642-A1 BENZYLISOQUINOLINE ALKALOID (BIA) PRECURSOR PRODUCING MICROBES, AND METHODS OF MAKING AND USING THE SAME THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2015-05-07 WO claimed
EP-2865762-A1 METHOD FOR PRODUCING PROTEIN-NUCLEIC ACID COMPLEX, AND METHOD FOR DETECTING TARGET SUBSTANCE Kyushu University, National University Corporation (JP) 2015-04-29 EP claimed
EP-2012795-A4 THERAPEUTIC TRITERPENOIDS UNIV MINNESOTA (US) 2009-07-22 EP claimed
EP-2012795-A2 THERAPEUTIC TRITERPENOIDS Regents of the University of Minnesota (US) 2009-01-14 EP claimed
WO-2007121352-A2 THERAPEUTIC TRITERPENOIDS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2007-10-25 WO claimed
EP-1751097-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES Proteotech, Inc. (US) 2007-02-14 EP claimed
WO-2005113489-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES PROTEOTECH, INC. (US) 2005-12-01 WO claimed
EP-0778284-A2 New 7-beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors MERCK &amp; CO. INC. (US) 1997-06-11 EP claimed
EP-0572166-A1 New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors MERCK & CO. INC. (US) 1993-12-01 EP claimed
EP-3861350-A1 USE OF LIGANDS DERIVED FROM RECEPTOR-BINDING DOMAIN OF PORCINE ENDOGENOUS RETROVIRUS TYPE B FOR DIAGNOSING SMVT-RELATED DISEASES Metafora Biosystems (FR) 2021-08-11 EP disclosed
WO-2020070330-A1 USE OF LIGANDS DERIVED FROM RECEPTOR-BINDING DOMAIN OF PORCINE ENDOGENOUS RETROVIRUS TYPE B FOR DIAGNOSING SMVT-RELATED DISEASES METAFORA BIOSYSTEMS (FR) 2020-04-09 WO disclosed
EP-0572166-A1 New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors MERCK & CO. INC. (US) 1993-12-01 EP disclosed
EP-0246709-A1 Recombinant DNA and cDNA, mRNA, protein, antibodies, and a method of detecting tumor cells Stichting Katholieke Universiteit (NL) 1987-11-25 EP disclosed